Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Completed · Phase 3

Conditions studied: Cerebral Stroke, Stroke, Acute, Cerebrovascular Stroke, Ischemic Attack, Transient

In brief

This study will determine if NXY-059 will improve recovery from an acute stroke. The study is designed to look at both overall recovery and recovery of motor function, for example muscle strengthen and coordination.

Key facts

Study ID

NCT00061022

Run by

AstraZeneca

People needed

3200

Starts

2003-05-01

Expected to finish

2006-09-01

Last updated by the study team

2010-11-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and females
• Acute ischemic stroke with limb weakness
• Onset of symptoms within 6 hours
• Full functional independence prior to the present stroke

You may not qualify if…

• Unconsciousness
• Subjects who are unlikely to complete the infusion of investigational product and/or are unlikely to undergo active medical management during that period due to a severe clinical condition.
• Severe illness with life expectancy less than 6 months.
• Known severe kidney disorder.
• Current known alcohol or illicit drug abuse or dependence.
• Pregnant or breast-feeding.
• Treatment with acetazolamide and methotrexate is not permitted during the infusion
• Participation in a previous clinical study within 30 days.
• Meets all other exclusion criteria.

Where it is running

• Research Site — Phoenix, Arizona, United States
• Research Site — Fort Smith, Arkansas, United States
• Research Site — Arcadia, California, United States
• Research Site — Concord, California, United States
• Research Site — Englewood, California, United States
• Research Site — La Jolla, California, United States
• Research Site — La Mesa, California, United States
• Research Site — Los Angeles, California, United States
• Research Site — Oceanside, California, United States
• Research Site — Palo Alto, California, United States
• Research Site — Poway, California, United States
• Research Site — Sacramento, California, United States
• Research Site — San Diego, California, United States
• Research Site — San Jose, California, United States
• Research Site — Englewood, Colorado, United States
• Research Site — Danbury, Connecticut, United States
• Research Site — Fairfield, Connecticut, United States
• Research Site — Delray Beach, Florida, United States
• Research Site — Fort Lauderdale, Florida, United States
• Research Site — Lakeland, Florida, United States
• Research Site — Lane Panama City, Florida, United States
• Research Site — Melbourne, Florida, United States
• Research Site — Naples, Florida, United States
• Research Site — Ocala, Florida, United States
• Research Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.